{"id":1389,"date":"2017-02-24T12:01:23","date_gmt":"2017-02-24T12:01:23","guid":{"rendered":"http:\/\/wwwro.anm.ro\/?page_id=1389"},"modified":"2025-05-13T14:22:39","modified_gmt":"2025-05-13T11:22:39","slug":"medicamente-supuse-unei-monitorizari-suplimentare","status":"publish","type":"page","link":"https:\/\/www.anm.ro\/en\/medicamente-de-uz-uman\/farmacovigilenta\/medicamente-supuse-unei-monitorizari-suplimentare\/","title":{"rendered":"Medicinal products under additional monitoring"},"content":{"rendered":"<p><strong>Medicines under additional monitoring<\/strong><br \/>\n<a href=\"https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/post-authorisation\/pharmacovigilance-post-authorisation\/medicines-under-additional-monitoring\/list-medicines-under-additional-monitoring\" target=\"_blank\" rel=\"noopener\">download document &#8230;<\/a> <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/p>\n<p><strong>Guideline on good pharmacovigilance practices (GVP),Module X &#8211; Additional monitoring<\/strong><br \/>\n<a href=\"https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-good-pharmacovigilance-practices-module-x-additional-monitoring_en.pdf\" target=\"_blank\" rel=\"noopener\">download document &#8230;<\/a> <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/p>\n<p><strong>List of medicines under additional monitoring<\/strong><br \/>\n<a href=\"https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/post-authorisation\/pharmacovigilance-post-authorisation\/medicines-under-additional-monitoring\/list-medicines-under-additional-monitoring\" target=\"_blank\" rel=\"noopener\">read more &#8230;<\/a><\/p>\n<p><strong>What does the black triangle mean?<\/strong><br \/>\n<a href=\"\/en\/_\/What%20does%20the%20black%20triangle%20mean.pdf\" target=\"_blank\" rel=\"noopener\">download document &#8230;<\/a> <img loading=\"lazy\" decoding=\"async\" src=\"\/imagini\/icon\/Adobe-Acrobat-Reader-CS2-icon.png\" width=\"32\" height=\"32\" align=\"absmiddle\" border=\"0\" \/><\/p>\n<div class=\"responsive-container\"><div class=\"lyte-wrapper\" title=\"Care este semnificatia triunghiului negru?\" style=\"width:853px;max-width:100%;margin:5px auto;\"><div class=\"lyMe hidef\" id=\"WYL_oAiQDeqQdVI\" itemprop=\"video\" itemscope itemtype=\"https:\/\/schema.org\/VideoObject\"><div><meta itemprop=\"thumbnailUrl\" content=\"https:\/\/www.anm.ro\/en\/wp-content\/plugins\/wp-youtube-lyte\/lyteCache.php?origThumbUrl=https%3A%2F%2Fi.ytimg.com%2Fvi%2FoAiQDeqQdVI%2Fmaxresdefault.jpg\" \/><meta itemprop=\"embedURL\" content=\"https:\/\/www.youtube.com\/embed\/oAiQDeqQdVI\" \/><meta itemprop=\"duration\" content=\"PT2M44S\" \/><meta itemprop=\"uploadDate\" content=\"2016-11-03T09:31:06.000Z\" \/><\/div><div id=\"lyte_oAiQDeqQdVI\" data-src=\"https:\/\/www.anm.ro\/en\/wp-content\/plugins\/wp-youtube-lyte\/lyteCache.php?origThumbUrl=https%3A%2F%2Fi.ytimg.com%2Fvi%2FoAiQDeqQdVI%2Fmaxresdefault.jpg\" class=\"pL\"><div class=\"tC\"><div class=\"tT\" itemprop=\"name\">Care este semnificatia triunghiului negru?<\/div><\/div><div class=\"play\"><\/div><div class=\"ctrl\"><div class=\"Lctrl\"><\/div><div class=\"Rctrl\"><\/div><\/div><\/div><noscript><a href=\"https:\/\/youtu.be\/oAiQDeqQdVI\" rel=\"nofollow\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.anm.ro\/en\/wp-content\/plugins\/wp-youtube-lyte\/lyteCache.php?origThumbUrl=https%3A%2F%2Fi.ytimg.com%2Fvi%2FoAiQDeqQdVI%2F0.jpg\" alt=\"Care este semnificatia triunghiului negru?\" width=\"853\" height=\"460\" \/><br \/>Watch this video on YouTube<\/a><\/noscript><meta itemprop=\"description\" content=\"www.anm.ro\"><\/div><\/div><div class=\"lL\" style=\"max-width:100%;width:853px;margin:5px auto;\"><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Medicines under additional monitoring download document &#8230; Guideline on good pharmacovigilance practices (GVP),Module X &#8211; Additional monitoring download document &#8230; [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":1074,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-1389","page","type-page","status-publish","hentry"],"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/www.anm.ro\/en\/wp-json\/wp\/v2\/pages\/1389","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.anm.ro\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.anm.ro\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.anm.ro\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.anm.ro\/en\/wp-json\/wp\/v2\/comments?post=1389"}],"version-history":[{"count":3,"href":"https:\/\/www.anm.ro\/en\/wp-json\/wp\/v2\/pages\/1389\/revisions"}],"predecessor-version":[{"id":10136,"href":"https:\/\/www.anm.ro\/en\/wp-json\/wp\/v2\/pages\/1389\/revisions\/10136"}],"up":[{"embeddable":true,"href":"https:\/\/www.anm.ro\/en\/wp-json\/wp\/v2\/pages\/1074"}],"wp:attachment":[{"href":"https:\/\/www.anm.ro\/en\/wp-json\/wp\/v2\/media?parent=1389"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}